Do socioeconomic factors and insurance explain racial/ethnic disparities in receipt of recommended breast cancer care?
R. A. Freedman, K. S. Virgo, Y. He, A. Pavluck, E. P. Winer, E. M. Ward and N. L. Keating Dana-Farber Cancer Institute, Boston, MA; American Cancer Society, Atlanta, GA; Harvard Medical School, Boston, MA Abstract 574 Background: Few data are available about how race/ethnicity, insurance, and socioeconomic status (SES) interrelate to influence breast cancer treatment. We examined care for a large national cohort of breast cancer patients to assess whether insurance and SES explained racial/ethnic differences in care. Methods: Among 662,117 white, black, and Hispanic women diagnosed with invasive breast cancer during 1998-2005 at hospitals reporting to the National Cancer Database, we used multivariable logistic regression to assess the probability of definitive locoregional therapy, hormone receptor testing, adjuvant hormonal therapy, and adjuvant chemotherapy, adjusting for patient and tumor characteristics. In additional models, we included insurance and area-level SES to determine w
